Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

Related Articles by Review for PubMed (Select 14600188)

1.

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.

Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Yasin M, Eaton GM, Lauer MA, Sheldon WS, Grines CL, Halpern S, Crowe T, Blankenship JC, Kerensky R.

JAMA. 2003 Nov 5;290(17):2292-300.

PMID:
14600188
2.

Therapeutic use of the high-density lipoprotein protein and peptides.

Marchesi M, Sirtori CR.

Expert Opin Investig Drugs. 2006 Mar;15(3):227-41. Review.

PMID:
16503760
4.
5.

Secondary preventive potential of lipid-lowering drugs. The Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).

de Faire U, Ericsson CG, Grip L, Nilsson J, Svane B, Hamsten A.

Eur Heart J. 1996 Dec;17 Suppl F:37-42. Review.

6.

Recombinant apolipoprotein A-IMilano for the treatment of cardiovascular diseases.

Calabresi L, Sirtori CR, Paoletti R, Franceschini G.

Curr Atheroscler Rep. 2006 Mar;8(2):163-7. Review.

PMID:
16510051
7.

HDL therapy for the acute treatment of atherosclerosis.

Newton RS, Krause BR.

Atheroscler Suppl. 2002 Dec;3(4):31-8. Review.

PMID:
12573361
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk